MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Pleural

Malignant pleural mesothelioma; mesothelioma of the lining of the lungs, or pleura.

Computational prediction of diagnosis and feature selection on mesothelioma patient health records.

PLos One 2019 January 10 [Link] Chicco D , Rovelli C BACKGROUND: Mesothelioma is a lung cancer that kills thousands of people worldwide annually, especially those with exposure to asbestos. Diagnosis of mesothelioma in patients often requires time-consuming imaging techniques and biopsies. Machine learning can provide for a more effective, cheaper, and faster patient diagnosis and feature […]

Comments Off on Computational prediction of diagnosis and feature selection on mesothelioma patient health records.

MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review.

Frontiers in Oncology 2018 December 21 [Link] Lo Russo G, Tessari A, Capece M, Galli G, de Braud F, Garassino MC, Palmieri D Abstract Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a variable incidence among different countries. Occupational asbestos exposure is the most important etiological factor and a very long latency […]

Comments Off on MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review.

Correlation of patient survival with clinical tumor measurements in malignant pleural mesothelioma.

European Radiology 2019 January 7 [Link] Li F, Ahmad M, Qayyum F, Straus CM, MacMahon H, Kindler H, Armato SG Abstract OBJECTIVES: To evaluate differences in the tumor response classifications that result from clinical measurements and to compare these response classifications with overall survival for patients with malignant pleural mesothelioma (MPM). METHODS: One hundred thirty-one […]

Comments Off on Correlation of patient survival with clinical tumor measurements in malignant pleural mesothelioma.

Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort.

F1000Research 2018 August 3 [Link] Amin W, Linkov F, Landsittel DP, Silverstein JC, Becich MJ Abstract Background: Malignant mesothelioma (MM) is a rare but deadly malignancy with about 3,000 new cases being diagnosed each year in the US. Very few studies have been performed to analyze factors associated with mesothelioma survival, especially for peritoneal presentation. […]

Comments Off on Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort.

Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India.

Indian Journal of Cancer 2018 April-June [Link] Hui M, Uppin SG, Bhaskar K, Kumar NN, Paramjyothi GK Abstract BACKGROUND: Malignant mesotheliomas are histologically heterogeneous neoplasms. Definite diagnosis requires a varied panel of immunohistochemical (IHC) markers to differentiate these from histological mimics. Only a few case series have been reported in the Indian literature where mesotheliomas […]

Comments Off on Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India.

Immunotherapy strategies for mesothelioma – the role of tumor specific neoantigens in a new era of precision medicine.

Expert Review of Respiratory Medicine 2018 December 30 [Link] Ye L, Ma S, Robinson BW, Creaney J Abstract Immunotherapy has long been considered a potential therapy for malignant mesothelioma and is currently being pursued as such. Some of the early phase clinical trials involving immunomodulators have demonstrated encouraging results and numerous clinical trials are underway […]

Comments Off on Immunotherapy strategies for mesothelioma – the role of tumor specific neoantigens in a new era of precision medicine.

The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma.

Journal of Clinical Pharmacy and Therapeutics 2018 December 2018 [Link] Mense ES, Smit AAJ, Crul M, Franssen EJF Abstract WHAT IS KNOWN AND OBJECTIVE: The use of cisplatin in the treatment of lung carcinoma is limited by nephrotoxicity. The aim of this study was to determine whether the incidence of nephrotoxicity in patients with lung […]

Comments Off on The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma.

Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma.

Journal of Thoracic and Cardiovascular Surgery 2019 January [Link] Hashimoto M, Takeuchi J, Takuwa T, Kuroda A, Nakamura A, Nakamichi T, Matsumoto S, Kondo N, Nakano T, Morimoto T, Hasegawa S Abstract OBJECTIVES: Definitive diagnosis of the T-component is sometimes challenging in malignant pleural mesothelioma (MPM). Pleural thickness has been reported to be a prognostic […]

Comments Off on Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma.

Biodistribution and Tumor Uptake of 67Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft.

Molecules 2018 November 29 [Link] Izquierdo-Sánchez V, Muñiz-Hernández S, Vázquez-Becerra H, Pacheco-Yepez J, Romero-Piña ME, Arrieta O, Medina LA Abstract Malignant pleural mesothelioma (MPM) is the most common tumor of the pulmonary pleura. It is a rare and aggressive malignancy, generally associated with continuous occupational exposure to asbestos. Only a multimodal-approach to treatment, based on […]

Comments Off on Biodistribution and Tumor Uptake of 67Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft.

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors.

BMC Research Notes 2018 December 5 [Link] Chee J, Watson MW, Chopra A, Nguyen B, Cook AM, Creaney J, Lesterhuis WJ, Robinson BW, Lee YCG, Nowak AK, Lake RA, McDonnell AM Abstract OBJECTIVE: Pleural effusion (PE) is a common feature of malignant pleural mesothelioma. These effusions typically contain lymphocytes and malignant cells. We postulated that […]

Comments Off on Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors.